Bicara Therapeutics BCAX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's preferred stock, shares authorized?
- Bicara Therapeutics (BCAX) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Bicara Therapeutics's preferred stock, shares authorized changed year-over-year?
- Bicara Therapeutics's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Bicara Therapeutics's preferred stock, shares authorized?
- Over 2 years (2023 to 2025), Bicara Therapeutics's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.